1. Home
  2. EVTC vs INBX Comparison

EVTC vs INBX Comparison

Compare EVTC & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

N/A

Current Price

$30.04

Market Cap

1.9B

Sector

Technology

ML Signal

N/A

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

N/A

Current Price

$70.40

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVTC
INBX
Founded
1988
2010
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2013
2024

Fundamental Metrics

Financial Performance
Metric
EVTC
INBX
Price
$30.04
$70.40
Analyst Decision
Buy
Buy
Analyst Count
6
4
Target Price
$37.00
★ $258.33
AVG Volume (30 Days)
★ 404.7K
270.4K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
★ 0.67%
N/A
EPS Growth
★ 27.17
N/A
EPS
★ 0.96
N/A
Revenue
★ $453,869,000.00
$1,300,000.00
Revenue This Year
$17.22
$53.85
Revenue Next Year
$8.86
$1,497.70
P/E Ratio
$31.17
★ N/A
Revenue Growth
11.48
★ 550.00
52 Week Low
$21.81
$57.30
52 Week High
$35.29
$155.29

Technical Indicators

Market Signals
Indicator
EVTC
INBX
Relative Strength Index (RSI) 41.11 37.87
Support Level $27.88 $66.98
Resistance Level $31.46 $97.67
Average True Range (ATR) 1.51 6.84
MACD -0.46 -1.05
Stochastic Oscillator 11.74 7.38

Price Performance

Historical Comparison
EVTC
INBX

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: